Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors

NCT06501183 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

17

Enrollment

OTHER

Sponsor class

Conditions

CDH17-positive Advanced Malignant Solid Tumors

Interventions

BIOLOGICAL: Anti-CDH17 CAR-T cells

Sponsor

Shanghai Pudong Hospital

Collaborators

[object Object]